Overview
Qing-xuan Wang practices practicing medicine in Wenzhou, China.
Wang is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Papillary Thyroid Cancer, Triple-Negative Breast Cancer, Thyroid Cancer, and Thyroid Nodule.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Qing-xuan Wang
Is Qing-xuan Wang a top-rated expert for Papillary Thyroid Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Qing-xuan Wang is classified as an Advanced expert for Papillary Thyroid Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Qing-xuan Wang participate in research or clinical trials?
Yes. Qing-xuan Wang has published 12 articles and abstracts on conditions like Papillary Thyroid Cancer. You can view a list of Qing-xuan Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Papillary Thyroid Cancer
- Experienced
- Thyroid CancerWang isExperienced. Learn about Thyroid Cancer.
- Thyroid NoduleWang isExperienced. Learn about Thyroid Nodule.
- Triple-Negative Breast Cancer